Alexion Not Scared Of Amgen Biosimilar Threat To Soliris

Companies Settled Eculizumab Litigation In US Earlier This Year

 
• By Dean Rudge
  
Balancing time and money
Alexion is not fazed by the potential for biosimilar competition to Soliris • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products